Publication Author: Harris_Jeffrey

• Assessment of health risk behaviors. A tool to inform consumers, providers, health care organizations, and purchasers.

  Thompson BL, Nelson DE, Caldwell B, Harris JR. Assessment of health risk behaviors. A tool to inform consumers, providers, health care organizations, and purchasers. Am J Prev Med. 1999 Jan;16(1):48-59.

  rakerr2

  January 1, 1999

• Measuring the public’s health in an era of accountability: lessons from HEDIS. Health Plan Employer Data and Information Set.

  Harris JR, Caldwell B, Cahill K. Measuring the public’s health in an era of accountability: lessons from HEDIS. Health Plan Employer Data and Information Set. Am J Prev Med. 1998 Apr;14(3 Suppl):9-13. Review.

  rakerr2

  April 1, 1998

• Monitoring system change: a new need for an old tool.

  Nelson DE, Thompson B, Smith SM, Harris JR, Madans J, Hunter EL. Monitoring system change: a new need for an old tool. Health Aff (Millwood). 1997 Sep-Oct;16(5):134-8.

  rakerr2

  September 1, 1997

• Nonparticipation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines.

  Clemens JD, van Loon FF, Rao M, Sack DA, Ahmed F, Chakraborty J, Khan MR, Yunus M, Harris JR, Svennerholm AM, et al. Nonparticipation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines. Am J Epidemiol. 1992 Apr 15;135(8)

  rakerr2

  April 15, 1992

• Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh.

  Sack DA, Clemens JD, Huda S, Harris JR, Khan MR, Chakraborty J, Yunus M, Gomes J, Siddique O, Ahmed F, et al. Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh. J Infect Dis. 1991 Aug

  rakerr2

  August 1, 1991

• Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera.

  Clemens JD, van Loon F, Sack DA, Chakraborty J, Rao MR, Ahmed F, Harris JR, Khan MR, Yunus M, Huda S, et al. Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J Infect Dis. 19

  rakerr2

  June 1, 1991

• ABO blood groups and the risk of diarrhea due to enterotoxigenic Escherichia coli.

  van Loon FP, Clemens JD, Sack DA, Rao MR, Ahmed F, Chowdhury S, Harris JR, Ali M, Chakraborty J, Khan MR, et al. ABO blood groups and the risk of diarrhea due to enterotoxigenic Escherichia coli. J Infect Dis. 1991 Jun;163(6):1243-6.

  rakerr2

  June 1, 1991

• Biotype as determinant of natural immunising effect of cholera.

  Clemens JD, van Loon F, Sack DA, Rao MR, Ahmed F, ChakrabortY J, Kay BA, Khan MR, Yunus MD, Harris JR, et al. Biotype as determinant of natural immunising effect of cholera. Lancet. 1991 Apr 13;337(8746):883-4.

  rakerr2

  April 13, 1991

• Sexually transmitted diseases in the AIDS era. Development of STD diagnostics for resource-limited settings is a global priority.

  Hitchcock PJ, Wasserheit JN, Harris JR, Holmes KK. Sexually transmitted diseases in the AIDS era. Development of STD diagnostics for resource-limited settings is a global priority. Sex Transm Dis. 1991 Apr-Jun;18(2):133-5.

  rakerr2

  April 1, 1991

• Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines.

  Clemens JD, Sack DA, Chakraborty J, Rao MR, Ahmed F, Harris JR, van Loon F, Khan MR, Yunis M, Huda S, et al. Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of t

  rakerr2

  October 1, 1990